459 related articles for article (PubMed ID: 15884203)
1. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
[TBL] [Abstract][Full Text] [Related]
2. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer.
Zhang F; Zhang ZL
Cell Biochem Biophys; 2015 Jun; 72(2):353-7. PubMed ID: 25582421
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer screening.
van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
[TBL] [Abstract][Full Text] [Related]
6. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
[TBL] [Abstract][Full Text] [Related]
7. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125.
Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R
Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205
[TBL] [Abstract][Full Text] [Related]
8. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
[TBL] [Abstract][Full Text] [Related]
9. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor].
Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N
Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441
[TBL] [Abstract][Full Text] [Related]
11. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
Varras M
Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
[TBL] [Abstract][Full Text] [Related]
12. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.
Bast RC
Trans Am Clin Climatol Assoc; 2004; 115():233-47; discussion 247-8. PubMed ID: 17060970
[TBL] [Abstract][Full Text] [Related]
13. Update on ovarian cancer screening.
Munkarah A; Chatterjee M; Tainsky MA
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
[TBL] [Abstract][Full Text] [Related]
14. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
[TBL] [Abstract][Full Text] [Related]
15. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
[TBL] [Abstract][Full Text] [Related]
16. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
[TBL] [Abstract][Full Text] [Related]
17. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.
Olivier RI; Lubsen-Brandsma MA; Verhoef S; van Beurden M
Gynecol Oncol; 2006 Jan; 100(1):20-6. PubMed ID: 16188302
[TBL] [Abstract][Full Text] [Related]
18. Preoperative assessment of ovarian tumors by CA 125 measurement and transvaginal color Doppler ultrasound.
Kupesić S; Vujisić S; Kurjak A; Mihaljević D; Radosević S
Acta Med Croatica; 2002; 56(1):3-10. PubMed ID: 12455447
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer screening by transvaginal color Doppler ultrasonography.
Rampone B; Rampone A; Tirabasso S; Panariello S; Rampone N
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):125-8. PubMed ID: 11526707
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
